News | December 12, 2024
AbbVie completes acquisition of Aliada Therapeutics
Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease
Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
Strengthening focus in Alzheimer's disease and neuroscience pipeline
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Agreement further expands Aptar Pharma’s leading respiratory portfolio
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
Subscribe To Our Newsletter & Stay Updated
